Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase NA 4Phase 3 4Phase 4 3Phase 1/2 3Phase 1 3Phase 2/3 1

Status

Unknown 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 22Other hematologic neoplasm 18Plasma cell 11Thoracic 3Gastrointestinal 3Breast 3Tumor-Agnostic 2Genitourinary 2Myeloid 1Head & Neck 1Gynecologic 1

Conditions

Breast Neoplasms 2Systemic Inflammatory Response Syndrome 1Postoperative Nausea and Vomiting 1Postoperative Complications 1Pain, Postoperative 1Breast Cancer Patients Treated With T-DXd 1

Interventions

Letrozole 23Docetaxel 17Cyclophosphamide 13Zoledronic Acid 12Trastuzumab 12Anastrozole 12exemestane 11Tamoxifen 11Paclitaxel 11Capecitabine 10Fulvestrant 8Epirubicin 8pegfilgrastim 7Saline Solution 7Bupivacaine 7pertuzumab 6liposomal doxorubicin 6abemaciclib 6Sodium Chloride 6Filgrastim 6Carboplatin 6pegylated granulocyte colony-stimulating factor 5palbociclib 5Ropivacaine 5Dexmedetomidine 5Bevacizumab 5ribociclib 4eribulin 4Vinorelbine 4Tranexamic Acid 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Dexamethasone × Breast × Clear all
NCT07254416 2025-11-28

A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients

Tianjin Medical University Cancer Institute and Hospital

Phase 4 Not yet recruiting
120 enrolled
Breast

Breast Cancer Patients Treated With T-DXd

NCT06300099 2024-03-12

Dexamethasone Versus Dexmedetomidine as Adjuncts to Serratus Anterior Plane Block

Al-Azhar University

Phase 4 Unknown
126 enrolled
Breast

Breast Neoplasms

NCT03125941 2019-12-02

DEX-MAS

Rigshospitalet, Denmark

Phase 4 Completed
130 enrolled 20 charts
Breast

Breast Neoplasms, Pain, Postoperative, Postoperative Complications, Systemic Inflammatory Response Syndrome, Postoperative Nausea and Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡